These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Face to face with lipoatrophy. An interview with David Nolan by Nelson Vergel. Nolan D GMHC Treat Issues; 2005; 19(3-4):1-6. PubMed ID: 16003843 [No Abstract] [Full Text] [Related]
11. The role of zidovudine in development of lipoatrophy. Moyle GJ AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181 [No Abstract] [Full Text] [Related]
13. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects. Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202 [No Abstract] [Full Text] [Related]
14. Report from the 12th Retrovirus Conference. Metabolic complications. Henry K AIDS Clin Care; 2005 Apr; 17(4):37-8. PubMed ID: 15875312 [No Abstract] [Full Text] [Related]
15. Meeting report from the XV International AIDS Conference. Metabolic complications. Currier J AIDS Clin Care; 2004 Sep; 16(9):73-4. PubMed ID: 15540318 [No Abstract] [Full Text] [Related]
16. Editorial comment: a plethora or options in multidrug-resistant HIV-1 infection. Katzenstein DA AIDS Read; 2008 Sep; 18(9):478-9. PubMed ID: 18828232 [No Abstract] [Full Text] [Related]
17. It's time to face the Zerit problem. Vergel N GMHC Treat Issues; 2003 Mar; 17(3):12. PubMed ID: 12728861 [No Abstract] [Full Text] [Related]
18. Fat loss prompts SA treatment switch. IAPAC Mon; 2006 Jul; 12(7):212. PubMed ID: 17096492 [No Abstract] [Full Text] [Related]
20. A review of the aetiology of dyslipidaemia and hyperlipidaemia in patients with HIV. Moyle G Int J STD AIDS; 2005 Oct; 16 Suppl 1():14-20; discussion 20-2, 41-3. PubMed ID: 16238827 [No Abstract] [Full Text] [Related] [Next] [New Search]